Completed
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2
NCT04887948
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, COVID-19, +16 more
- Locations
-
- Anaheim Clinical Trials, LLC Anaheim, California, United States
- Diablo Clinical Research, Inc. Walnut Creek, California, United States
- Alliance for Multispecialty Research, LLC Coral Gables, Florida, United States
- Indago Research & Health Center, Inc Hialeah, Florida, United States